| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |